Gastric bypass drug study pulled before starting
NCT ID NCT04423588
First seen Jun 11, 2026 · Last updated Jun 23, 2026 · Updated 1 time
Summary
This study was designed to see how well the stomach-acid drug dexlansoprazole is absorbed before and after gastric bypass surgery, and how often ulcers occur afterward. It planned to enroll smokers with obesity who were scheduled for surgery. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexlansoprazole (Dexilant)
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.